https://www.selleckchem.com/products/Cyt387.html
Inosine monophosphate dehydrogenase-1 is the target of mycophenolate mofetil. This research investigated the association between the gene polymorphism of inosine monophosphate dehydrogenase-1 and effectiveness of mycophenolate mofetil therapy in neuromyelitis optica spectrum disorder patients. Fifty-nine neuromyelitis optica spectrum disorder patients accepted Mycophenolate Mofetil therapy for 1 year at least were divided into two groups relapsing (n=21) and non-relapsing (n=38). Four single-nucleotide polymorphisms (SNPs rs2228075, rs22
Like
Comment
Share
